NOT FOR DISTRIBUTION TO NEWSWIRE SERVICES IN THE UNITED STATES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS.
TORONTO, Feb. 27, 2019 (GLOBE NEWSWIRE) -- MPX International Corporation (“MPX International” or the “Company”) (CSE: MPXI) announces that a total of 3,175,000 stock options to purchase common shares of MPX International were granted to officers, directors, employees and consultants of the Company and its subsidiaries at an exercise price of $0.59 per share and expiring on February 26, 2024. The grant is subject to regulatory approval.
Under the Company’s stock option plan (the “Plan”), 9.77% of the issued and outstanding common shares or 4,529,250 common shares are reserved for issuance, including the above grant, and the Company may grant an additional 108,804 options under the Stock Option Plan representing 0.23% of the issued and outstanding common shares.
About MPX International Corporation
MPX International Corporation is focused on developing and operating assets across the global cannabis industry with an emphasis on cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient.
Cautionary Statement Regarding Forward-Looking Information
This news release includes certain “forward-looking statements” under applicable Canadian securities legislation that are not historical facts. Forward-looking statements involve risks, uncertainties, and other factors that could cause actual results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements in this news release include, but are not limited to, MPX International’s objectives and intentions. Forward-looking statements are necessarily based on a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic and social uncertainties; litigation, legislative, environmental and other judicial, regulatory, political and competitive developments; delay or failure to receive board, shareholder or regulatory approvals; those additional risks set out in MPX International’s public documents filed on SEDAR at www.sedar.com; and other matters discussed in this news release. Although MPX International believes that the assumptions and factors used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Except where required by law, MPX International disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
For further information, please contact:
MPX International Corporation
W. Scott Boyes, Chairman, President and CEO
T: +1-416-840-3725
info@mpxinternationalcorp.com
www.mpxinternationalcorp.com
Investor Relations
KCSA Strategic Communications
Phil Carlson / Elizabeth Barker
pcarlson@ksca.com / ebarker@kcsa.com
212.896.1233 / 212.896.1203
Media Relations
KCSA Strategic Communications
Anne Donohoe
Adonohoe@kcsa.com
212-896-1265